GSA CAPITAL PARTNERS LLP - BIOSCRIP INC ownership

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of BIOSCRIP INC
ValueSharesWeighting
Q3 2018$47,000
-93.2%
15,237
-93.6%
0.00%
-91.2%
Q2 2018$692,000
-21.4%
236,294
-34.0%
0.03%
-27.7%
Q1 2018$880,000
+18.9%
357,806
+40.7%
0.05%
+4.4%
Q4 2017$740,000
-13.7%
254,306
-18.4%
0.04%
-22.4%
Q3 2017$857,000
+4661.1%
311,500
+2811.2%
0.06%
+5700.0%
Q1 2017$18,000
-30.8%
10,700
-56.7%
0.00%
-50.0%
Q4 2016$26,000
-87.8%
24,700
+2.0%
0.00%
-88.2%
Q3 2013$213,000
-9.4%
24,219
+69.9%
0.02%
-39.3%
Q2 2013$235,00014,2550.03%
Other shareholders
BIOSCRIP INC shareholders Q3 2023
NameSharesValueWeighting ↓
Venor Capital Management LP 12,005,453$20,409,00010.92%
Coliseum Capital Management, LLC 5,622,410$9,558,0004.30%
Alta Fundamental Advisers LLC 2,217,164$3,769,0004.07%
WYNNEFIELD CAPITAL INC 3,800,000$6,460,0002.37%
ARDSLEY ADVISORY PARTNERS LP 5,280,000$8,976,0001.40%
NORTH TIDE CAPITAL, LLC 3,000,000$5,100,0000.78%
Camber Capital Management LP 10,180,000$17,306,0000.70%
PERKINS CAPITAL MANAGEMENT INC 310,500$528,0000.54%
ROANOKE ASSET MANAGEMENT CORP/ NY 233,280$397,0000.19%
Eidelman Virant Capital 140,000$238,0000.16%
View complete list of BIOSCRIP INC shareholders